Neurocrine Biosciences Inc. share price logo

Neurocrine Biosciences Inc. Share Price

NASDAQ: NBIX

Large Cap

$140.30

-1.57

(-1.11%)

Live

as on

Neurocrine Biosciences Inc. Stock Performance

as on September 15, 2025 at 10:37 pm IST

  • Day's Low

    Day's High

    $139.38
    $141.81
    downward going graph

    0.66%

    Downside

    1.08%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $84.23
    $154.61
    downward going graph

    39.96%

    Downside

    10.20%

    Upside

    downward going graph

Neurocrine Biosciences Inc. share price movements today

Previous Close
$141.87
Open
$141.75
Volume
188.6K
Day's Low - High
$139.38 - $141.81
52 Week Low - High
$84.23 - $154.61

Neurocrine Biosciences Inc. Historical Returns

1 Month Return
+ 6.75 %
3 Month Return
+ 14.05 %
1 Year Return
+ 16.05 %
3 Year Return
+ 32.68 %
5 Year Return
+ 36.02 %

Neurocrine Biosciences Inc. Stock Fundamentals & Key Indicators

Check Neurocrine Biosciences Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$14.1B

EPS (TTM)

6.739

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.68%

PE Ratio (TTM)

41.97

Industry PE ratio

16.65525641025641

P/B Ratio

41.9734

PEG Ratio

0.2733

EBITDA

527.6M

Revenue (TTM)

2.5B

Profit Margin

13.88%

Return On Equity TTM

13.39%

Neurocrine Biosciences Inc. Stock Valuation

Track how Neurocrine Biosciences Inc. P/E has moved over time to understand its valuation trends.

Neurocrine Biosciences Inc. in the last 5 years

  • Overview

  • Trends

Lowest (21.72x)

June 30, 2025

Industry (16.66x)

September 15, 2025

Today (41.97x)

September 15, 2025

Highest (178.01x)

September 30, 2022

LowHigh

Today’s Price to Earnings Ratio: 41.97x

Neurocrine Biosciences Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Neurocrine Biosciences Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$14.1B36.02%41.9713.88%
BUY$18.3BNA15.840.36%
BUY$44.1BNA21.813.81%
BUY$65.7B-8.68%25.5127.83%

Stock Returns calculator for Neurocrine Biosciences Inc. Stock including INR - Dollar returns

The Neurocrine Biosciences Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Neurocrine Biosciences Inc. investment value today

Current value as on today

₹1,19,750

Returns

₹19,750

(+19.75%)

Returns from Neurocrine Biosciences Inc. Stock

₹14,765 (+14.76%)

Dollar Returns*

₹4,985 (+4.99%)

Analyst Recommendation on Neurocrine Biosciences Inc. Stock

Based on 34 analysts

BUY

76.47%

Buy

23.53%

Hold

0.00%

Sell

Based on 34 analysts, 76.47% of analysts recommend a 'BUY' rating for Neurocrine Biosciences Inc.. Average target price of $168.25

Neurocrine Biosciences Inc. Share Price Target

Get share price movements and forecasts by analysts on Neurocrine Biosciences Inc..

What analysts predicted

16.61%UPSIDE

Target Price

$168.25

Current Price

$140.3

Analyzed by

34 Analysts

Target

$168.25

Neurocrine Biosciences Inc. target price $168.25, a slight upside of 16.61% compared to current price of $140.3. According to 34 analysts rating.

Neurocrine Biosciences Inc. Stock's Interest Amongst Investors

Search interest for Neurocrine Biosciences Inc. Stock has increased by 16% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:16% versus previous 30 day period

Neurocrine Biosciences Inc. Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
420
452
498
515
515
590
622
627
572
687
Gross Profit
411
441
487
506
507
581
614
618
563
676
Operating Income
-114
73
141
150
99
145
183
142
23
145
EBITDA
-97
126
146
205
111
155
191
181
31
152
Interest Expense
1
1
1
1
1
49
-
-
-
-
Depreciation
5
5
5
5
6
7
6
7
7
7
Income Before Tax
-103
121
115
198
34
98
190
162
14
159
Income Tax Expense
-26
26
32
50
-8
33
60
59
6
52
Net Income
-76
95
83
147
43
65
129
103
7
107
Net Profit Margin
-18.22%
21.10%
16.66%
28.67%
8.42%
11.01%
20.86%
16.43%
1.38%
15.64%

Neurocrine Biosciences Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
19
15
161
451
788
1,045
1,133
1,488
1,887
2,355
Gross Profit
19
15
160
446
780
1,035
1,119
1,465
1,847
2,321
Operating Income
-94
-147
-131
36
72
163
102
249
250
570
EBITDA
-87
-139
-120
40
85
148
138
264
416
639
Interest Expense
-
-
19
30
32
32
25
7
4
126
Depreciation
-
-
2
4
7
8
10
15
20
27
Income Before Tax
-88
-141
-142
21
46
106
101
213
332
486
Income Tax Expense
-6
-7
17
0
9
-300
11
59
82
144
Net Income
-88
-141
-142
21
37
407
89
154
249
341
Net Profit Margin
-449.84%
-940.60%
-88.19%
4.68%
4.69%
38.94%
7.90%
10.38%
13.23%
14.49%

Neurocrine Biosciences Inc. Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
95
83
147
43
65
129
103
7
107
Operating Cash Flow
179
212
123
130
64
158
242
64
102
Investing Cash Flow
-125
-97
-201
-55
-28
24
-68
14
-29
Financing Cash Flow
2
18
35
69
-293
26
-290
-117
-3
Change in Cash
56
133
-42
145
-256
209
-116
-38
69

Neurocrine Biosciences Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-141
-142
21
37
407
89
154
249
341
Operating Cash Flow
-106
-94
101
152
228
256
339
389
595
Investing Cash Flow
112
-250
-242
-211
4
-130
-177
-467
-126
Financing Cash Flow
2
516
29
27
-157
27
-234
65
-486
Change in Cash
9
171
-112
-31
74
153
-73
-11
-18

Global Institutional Holdings in Neurocrine Biosciences Inc.

Funds
Holdings
BlackRock Inc
14.8%
Vanguard Group Inc
10.02%
Dodge & Cox
5.58%
State Street Corp
4.9%
JPMorgan Chase & Co
2.69%

Insights on Neurocrine Biosciences Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 572.6M → 687.5M (in $), with an average increase of 16.7% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, NBIX stock has moved up by 6.7%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 7.9M → 107.5M (in $), with an average increase of 92.7% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, United Therapeutics Corporation has given 83.6% return, outperforming this stock by 50.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, United Therapeutics Corporation has given 19.4% return, outperforming this stock by 3.4%

About Neurocrine Biosciences Inc.

neurocrine biosciences, inc of san diego is a product based biopharmaceutical company focusing on the development and commercialization of innovative pharmaceutical products to treat unmet medical needs. the company's research and development efforts are focused on neurological and endocrine diseases and disorders. our product candidates address some of the largest pharmaceutical markets in the world including endometriosis, irritable bowel syndrome, anxiety, depression, pain, diabetes, insomnia, and other neurological and endocrine related diseases and disorders
OrganisationNeurocrine Biosciences Inc.
Headquarters12780 El Camino Real, San Diego, CA, United States, 92130
IndustryHealth Technology
CEOMr. Kyle W. Gano Ph.D.
E-voting on sharesClick here to vote

Key Management of Neurocrine Biosciences Inc.

Name

Title

Dr. Jude Onyia Ph.D.

Chief Scientific Officer

Dr. Lawrence Steinman BA, M.D., Ph.D.

Co-Founder of Neurocrine

Mr. Lewis Choi

Chief Information Officer

Jane Sorensen

Head of Investor Relations

Mr. Kyle W. Gano Ph.D.

CEO & Director

Mr. Eric S. Benevich

Chief Commercial Officer

Dr. Eiry Wyn Roberts M.D.

Strategic Advisor

Dr. Wylie W. Vale Ph.D.

Co-Founder

Mr. Darin M. Lippoldt Esq.

Chief Legal Officer & Corporate Secretary

Mr. Matthew C. Abernethy CPA

Chief Financial Officer

FAQs

What is Neurocrine Biosciences Inc. share price today?

Neurocrine Biosciences Inc. share price today is $140.3 as on . Neurocrine Biosciences Inc. share today touched a day high of $141.81 and a low of $139.38.

What is the 52 week high and 52 week low for Neurocrine Biosciences Inc. share?

Neurocrine Biosciences Inc. share touched a 52 week high of $154.61 on and a 52 week low of $84.23 on . Neurocrine Biosciences Inc. stock price today i.e. is trending at $140.3,which is 9.26% down from its 52 week high and 66.57% up from its 52 week low.

What is Neurocrine Biosciences Inc.'s market capitalisation today?

Neurocrine Biosciences Inc. market capitalisation is $0.01T as on .

How to invest in Neurocrine Biosciences Inc. Stock (NBIX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Neurocrine Biosciences Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Neurocrine Biosciences Inc. Shares that will get you 0.0107 shares as per Neurocrine Biosciences Inc. share price of $140.3 per share as on September 15, 2025 at 10:37 pm IST.

What is the minimum amount required to buy Neurocrine Biosciences Inc. Stock (NBIX) from India?

Indian investors can start investing in Neurocrine Biosciences Inc. (NBIX) shares with as little as ₹88.141 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Neurocrine Biosciences Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Neurocrine Biosciences Inc. share’s latest price of $140.3 as on September 15, 2025 at 10:37 pm IST, you will get 0.0713 shares of Neurocrine Biosciences Inc.. Learn more about fractional shares .

What are the returns that Neurocrine Biosciences Inc. has given to Indian investors in the last 5 years?

Neurocrine Biosciences Inc. stock has given 36.02% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?